Related Experiment Video
Updated: Nov 4, 2025

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Percutaneous Coronary Intervention in Transcatheter Aortic Valve Implantation Patients: Overview and Practical
Maren Weferling1,2, Christian W Hamm1,2,3, Won-Keun Kim1,2,3,4
1Department of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Insights
Coronary artery disease (CAD) is common in patients receiving transcatheter aortic valve implantation (TAVI). This review examines the role of percutaneous coronary intervention (PCI) in TAVI patients, offering guidance for clinical practice.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary artery disease (CAD) affects a significant portion (40-75%) of patients undergoing transcatheter aortic valve implantation (TAVI) for severe aortic stenosis.
- The expanding indications for TAVI in younger, lower-risk patients suggest an increased future need for coronary interventions.
- Current guidelines recommend percutaneous coronary intervention (PCI) before TAVI, but optimal timing lacks robust evidence.
Purpose of the Study:
- To review the prevalence and clinical impact of CAD in TAVI patients.
- To discuss the challenges and implications of performing coronary angiography (CA) and PCI in the context of TAVI.
- To provide practical guidance for managing CAD and PCI in TAVI recipients.
Main Methods:
- Literature review of current data on CAD and PCI in TAVI patients.
- Analysis of European and US guidelines regarding PCI timing.
- Discussion of technical considerations for CA and PCI post-TAVI.
Main Results:
- CAD is highly prevalent in TAVI candidates, necessitating careful management.
- The optimal timing for PCI relative to TAVI remains controversial due to limited evidence.
- Post-TAVI coronary procedures can be technically challenging depending on the prosthetic valve.
Conclusions:
- Interventionalists must be knowledgeable about transcatheter heart valves to navigate potential complications during coronary procedures.
- Further research is needed to establish optimal timing for PCI in TAVI patients.
- This review offers insights for practical management of CAD in the TAVI population.
Abstract:
Coronary artery disease (CAD) is present in 40-75% of patients undergoing transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis. Currently, the indication for TAVI is expanding toward younger patients at lower surgical risk. Given the progressive nature of CAD, the necessity for coronary angiography (CA), including percutaneous coronary intervention (PCI), will subsequently increase as in the future TAVI patients will be younger and have a longer life expectancy. Data on the impact of PCI in patients with severe CAD scheduled for TAVI are controversial, and although European and US guidelines recommend PCI before TAVI, the optimal timing for PCI remains unclear due to a lack of evidence. Depending on the valve type, position, and axial alignment of the implanted device, CA and/or PCI after TAVI can be challenging. Hence, every interventionalist should be familiar with the different types of transcatheter heart valves and their characteristics and technical issues that can arise during invasive coronary procedures. This review provides an overview of current data regarding the prevalence and clinical implications of CAD and PCI in TAVI patients and includes useful guidance for practical management in the clinical routine.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Mitral Stenosis III: Medical Management
Angina IV: Management
Cardiac Catheterization IV: Nursing Management
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care

